Find clinical trials for Lung Cancer in Nashville, TN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Nashville, TN, USA:
Lung cancer screening with low-dose chest computed tomography (CT) is currently recommended for high-risk individuals who are 50 to...
Nashville, Tennessee, United States and 6 other locations
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
Nashville, Tennessee, United States and 18 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Nashville, Tennessee, United States and 210 other locations
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
Nashville, Tennessee, United States of America and 33 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Nashville, Tennessee, United States and 124 other locations
This study will evaluate two study drugs called ubamatamab and marlotamig, to see if they can help treat advanced or metastatic Non-Small Cell Lung...
Phase 2
Nashville, Tennessee, United States and 16 other locations
This study was designed to evaluate safety and antitumor activity of HER3-DXd in two parts: Dose Escalation and Dose Expansion.In Dose Escalation, HE...
Phase 1
Nashville, Tennessee, United States and 36 other locations
to assess the safety and tolerability of BMS-986525 alone and in combination with Pumitamig in participants with Relapsed/Refractory Small Cell Lung...
Phase 1, Phase 2
Nashville, Tennessee, United States of America and 12 other locations
HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...
Phase 1
Nashville, Tennessee, United States of America and 21 other locations
in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung...
Phase 1, Phase 2
Nashville, Tennessee, United States of America and 58 other locations
Clinical trials
Research sites
Resources
Legal